{"altmetric_id":10881987,"counts":{"readers":{"mendeley":2,"citeulike":0,"connotea":0},"total":{"posts_count":9},"twitter":{"unique_users_count":9,"unique_users":["DoveGeriatrics","DoveTherapeutic","GrupoAF_VIH_SEF","GRUPOCRONOSSEF1","Sensingcrackest","franballestero1","CGuindel","mdialop1","eva_del_sil"],"posts_count":9}},"selected_quotes":["Polypharmacy in HIV positive older adults","Polypharmacy in older adults with HIV infection compared with the general population."],"citation":{"abstract":"The percentage of older HIV-positive patients is growing, with an increase in age-related comorbidities and concomitant medication.\nTo quantify polypharmacy and profile types of non-antiretroviral drugs collected at community pharmacies in 2014 by HIV-positive individuals on antiretroviral therapy and to compare these findings with those of the general population.\nHIV-positive patients (n=199) were compared with a group of patients from the general population (n=8,172), aged between 50 and 64 years. The factors compared were prevalence of polypharmacy (\u22655 comedications with cumulative defined daily dose [DDD] per drug over 180), percentage of patients who collected each therapeutic class of drug, and median duration for each drug class (based on DDD). Results were stratified by sex.\nPolypharmacy was more common in HIV-positive males than in the male general population (8.9% vs 4.4%, P=0.010). Polypharmacy was also higher in HIV-positive females than in the female general population (11.3% vs 3.4%, P=0.002). Percentage of HIV-positive patients receiving analgesics, anti-infectives, gastrointestinal drugs, central nervous system (CNS) agents, and respiratory drugs was higher than in the general population, with significant differences between male populations. No differences were observed in proportion of patients receiving cardiovascular drugs. The estimated number of treatment days (median DDDs) were higher in HIV-positive males than in males from the general population for anti-infectives (32.2 vs 20.0, P<0.001) and CNS agents (238.7 vs 120.0, P=0.002). A higher percentage of HIV-positive males than males from the general population received sulfonamides (17.1% vs 1.5%, P<0.001), macrolides (37.1% vs 24.9%, P=0.020), and quinolones (34.3% vs 21.2%, P=0.009).\nPolypharmacy is more common in HIV-positive older males and females than in similarly aged members of the general population. HIV-positive patients received more CNS drugs and anti-infectives, specifically sulfonamides, macrolides, and quinolones, but there were no differences in the percentage of patients receiving cardiovascular drugs. It is essential to investigate nonantiretroviral therapy medication use in the HIV-positive population to ensure these patients receive appropriate management.","altmetric_jid":"4f6fa6113cf058f610006f02","authors":["Mercedes Gimeno-Gracia","Maria Jose Crusells-Canales","Francisco Javier Armesto-Gomez","Vicente Compaired-Turlan","Maria Jose Rabanaque-Hernandez","Gimeno-Gracia, Mercedes","Crusells-Canales, Mar\u00eda Jos\u00e9","Armesto-G\u00f3mez, Francisco Javier","Compaired-Turl\u00e1n, Vicente","Rabanaque-Hern\u00e1ndez, Mar\u00eda Jos\u00e9"],"doi":"10.2147\/cia.s108072","endpage":"1157","first_seen_on":"2016-08-29T02:30:08+00:00","funders":["niehs"],"issns":["1178-1998"],"journal":"Clinical Interventions in Aging","last_mentioned_on":1478191777,"links":["https:\/\/www.dovepress.com\/polypharmacy-in-older-adults-with-human-immunodeficiency-virus-infecti-peer-reviewed-article-CIA","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27616883","https:\/\/www.dovepress.com\/polypharmacy-in-older-adults-with-human-immunodeficiency-virus-infecti-peer-reviewed-article-CIA?platform=hootsuite"],"pdf_url":"https:\/\/www.dovepress.com\/getfile.php?fileID=32095","pmid":"27616883","pubdate":"2016-08-26T00:00:00+00:00","publisher":"Dove Press","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"1149","subjects":["geriatrics"],"title":"Polypharmacy in older adults with human immunodeficiency virus infection compared with the general population","type":"article","volume":"11","mendeley_url":"http:\/\/www.mendeley.com\/research\/polypharmacy-older-adults-human-immunodeficiency-virus-infection-compared-general-population-2"},"altmetric_score":{"score":4.7,"score_history":{"1y":4.7,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":4.7},"context_for_score":{"all":{"total_number_of_other_articles":7639268,"mean":6.5692022176954,"rank":1486435,"this_scored_higher_than_pct":80,"this_scored_higher_than":6144782,"rank_type":"exact","sample_size":7639268,"percentile":80},"similar_age_3m":{"total_number_of_other_articles":245249,"mean":12.23747316186,"rank":65375,"this_scored_higher_than_pct":73,"this_scored_higher_than":179409,"rank_type":"exact","sample_size":245249,"percentile":73},"this_journal":{"total_number_of_other_articles":943,"mean":4.9015838641189,"rank":214,"this_scored_higher_than_pct":77,"this_scored_higher_than":728,"rank_type":"exact","sample_size":943,"percentile":77},"similar_age_this_journal_3m":{"total_number_of_other_articles":55,"mean":7.8912962962963,"rank":13,"this_scored_higher_than_pct":76,"this_scored_higher_than":42,"rank_type":"exact","sample_size":55,"percentile":76}}},"demographics":{"poster_types":{"member_of_the_public":6,"practitioner":3},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":3,"Members of the public":6}},"mendeley":{"by_status":{"Student  > Master":1,"Student  > Bachelor":1},"by_discipline":{"Medicine and Dentistry":1,"Pharmacology, Toxicology and Pharmaceutical Science":1}}},"geo":{"twitter":{"ES":4}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/DoveGeriatrics\/statuses\/770086032960282626","license":"gnip","citation_ids":[10881987],"posted_on":"2016-08-29T02:29:52+00:00","author":{"name":"Dove Press Geriatric","url":"http:\/\/www.dovepress.com\/browse_journals.php?pa=view&cat_id=11","image":"https:\/\/pbs.twimg.com\/profile_images\/294784223\/DoveLogoBlock-75_normal.jpg","description":"Latest articles about Geriatrics and Aging published in Dove Press open access medical and scientific journals","id_on_source":"DoveGeriatrics","tweeter_id":"53263178","geo":{"lt":null,"ln":null},"followers":71},"tweet_id":"770086032960282626"},{"url":"http:\/\/twitter.com\/DoveTherapeutic\/statuses\/770087509963501570","license":"gnip","citation_ids":[10881987],"posted_on":"2016-08-29T02:35:44+00:00","author":{"name":"DovePressTherapeutic","url":"http:\/\/www.dovepress.com\/browse_journals.php?pa=view&cat_id=24","image":"https:\/\/pbs.twimg.com\/profile_images\/294900345\/DoveLogoBlock-75_normal.jpg","description":"Latest articles covering all aspects of drug development, testing and applications, published in Dove Press open access medical and scientific journals","id_on_source":"DoveTherapeutic","tweeter_id":"53283807","geo":{"lt":null,"ln":null},"followers":34},"tweet_id":"770087509963501570"},{"url":"http:\/\/twitter.com\/GrupoAF_VIH_SEF\/statuses\/777823816282144768","license":"gnip","citation_ids":[10881987],"posted_on":"2016-09-19T10:57:03+00:00","author":{"name":"GrupoAF_VIH_SEFH","url":"http:\/\/gruposdetrabajo.sefh.es\/afvih\/","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000442408067\/344a5b716012dc413a244f0688480a85_normal.jpeg","description":"Grupo de Atenci\u00f3n Farmac\u00e9utica al Paciente VIH (SEFH)","id_on_source":"GrupoAF_VIH_SEF","tweeter_id":"1853925432","geo":{"lt":40,"ln":-4,"country":"ES"},"followers":1596},"tweet_id":"777823816282144768"},{"url":"http:\/\/twitter.com\/GRUPOCRONOSSEF1\/statuses\/793906031172657152","license":"gnip","citation_ids":[10881987],"posted_on":"2016-11-02T20:02:02+00:00","author":{"name":"GrupoCronosSEFH","url":"http:\/\/gruposdetrabajo.sefh.es\/cronos\/","image":"https:\/\/pbs.twimg.com\/profile_images\/2781008919\/b84bc8dc1ad1726af5a62861976a790d_normal.png","description":"Es clave para el futuro del farmac\u00e9utico participar en el desarrollo de modelos eficientes y estrategias para afrontar cronicidad, comorbilidad y fragilidad.","id_on_source":"GRUPOCRONOSSEF1","tweeter_id":"703484533","geo":{"lt":40,"ln":-4,"country":"ES"},"followers":1204},"tweet_id":"793906031172657152"},{"url":"http:\/\/twitter.com\/Sensingcrackest\/statuses\/793918065708765184","license":"gnip","rt":["GRUPOCRONOSSEF1"],"citation_ids":[10881987],"posted_on":"2016-11-02T20:49:51+00:00","author":{"name":"Fede P.S.","image":"https:\/\/pbs.twimg.com\/profile_images\/413780358685917185\/kBUIYYsm_normal.jpeg","description":"Jug\u00f3n excepcional con la actitud mental de un crack: residi\u00e9ndome en Farmacia Hospitalaria sin perder la esencia forman el pack...y lo sabes --","id_on_source":"Sensingcrackest","tweeter_id":"2253710611","geo":{"lt":null,"ln":null},"followers":225},"tweet_id":"793918065708765184"},{"url":"http:\/\/twitter.com\/franballestero1\/statuses\/793923630065446912","license":"gnip","rt":["GRUPOCRONOSSEF1"],"citation_ids":[10881987],"posted_on":"2016-11-02T21:11:58+00:00","author":{"name":"fran ballesteros","image":"https:\/\/pbs.twimg.com\/profile_images\/875743221216944130\/o6njpaLZ_normal.jpg","description":"BSc Pharm + MSc Micro","id_on_source":"franballestero1","tweeter_id":"293609388","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":236},"tweet_id":"793923630065446912"},{"url":"http:\/\/twitter.com\/CGuindel\/statuses\/794123217619353600","license":"gnip","rt":["GRUPOCRONOSSEF1"],"citation_ids":[10881987],"posted_on":"2016-11-03T10:25:03+00:00","author":{"name":"Conchi Guindel","image":"https:\/\/pbs.twimg.com\/profile_images\/616991246305894401\/q2boVw2j_normal.jpg","id_on_source":"CGuindel","tweeter_id":"341720785","geo":{"lt":null,"ln":null},"followers":140},"tweet_id":"794123217619353600"},{"url":"http:\/\/twitter.com\/mdialop1\/statuses\/794214040054755328","license":"gnip","rt":["GRUPOCRONOSSEF1"],"citation_ids":[10881987],"posted_on":"2016-11-03T16:25:57+00:00","author":{"name":"M\u00aa Dolores D\u00edaz","image":"https:\/\/pbs.twimg.com\/profile_images\/577061281481551872\/zPv8ngZE_normal.jpeg","id_on_source":"mdialop1","tweeter_id":"2824633418","geo":{"lt":null,"ln":null},"followers":34},"tweet_id":"794214040054755328"},{"url":"http:\/\/twitter.com\/eva_del_sil\/statuses\/794219996121538560","license":"gnip","rt":["GRUPOCRONOSSEF1"],"citation_ids":[10881987],"posted_on":"2016-11-03T16:49:37+00:00","author":{"name":"Eva Delgado Silveira","image":"https:\/\/pbs.twimg.com\/profile_images\/677908801752850433\/gkLTkdCJ_normal.jpg","description":"Doctora en Farmacia y especialista en Farmacia Hospitalaria. Hospital Ram\u00f3n y Cajal. Coordinadora grupo CRONOS (SEFH)","id_on_source":"eva_del_sil","tweeter_id":"836268403","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":249},"tweet_id":"794219996121538560"}]}}